These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Factor XII (HAGEMAN FACTOR)]. Kase F; Klír P; Pospísil J; Poucková P Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809 [TBL] [Abstract][Full Text] [Related]
4. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077 [TBL] [Abstract][Full Text] [Related]
5. [Correlation of complement system with coagulation, fibrinolysis, and kinin generation]. Kondo M Rinsho Ketsueki; 1976 Jan; 17(1):1-14. PubMed ID: 135104 [No Abstract] [Full Text] [Related]
6. Activation, activities and pharmacologically active products of complement. Vogt W Pharmacol Rev; 1974 Jun; 26(2):125-69. PubMed ID: 4609350 [No Abstract] [Full Text] [Related]
7. The "Hageman" connection: interrelationships of blood coagulation, fibrinogenolysis, kinin generation, and complement activation. Murano G Przegl Lek; 1981; 38(10):709-13. PubMed ID: 7330256 [No Abstract] [Full Text] [Related]
8. Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response. Kaplan AP; Austen KF J Allergy Clin Immunol; 1975 Dec; 56(6):491-506. PubMed ID: 1107395 [No Abstract] [Full Text] [Related]
9. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. Schreiber AD; Kaplan AP; Austen KF J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226 [TBL] [Abstract][Full Text] [Related]
10. The complement system of man. I. Ruddy S; Gigli I; Austen KF N Engl J Med; 1972 Sep; 287(10):489-95. PubMed ID: 4114930 [No Abstract] [Full Text] [Related]
11. Plasma inhibitors of the Hageman factor dependent pathways. Schreiber AD Semin Thromb Hemost; 1976 Jul; 3(1):32-51. PubMed ID: 799348 [TBL] [Abstract][Full Text] [Related]
12. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. Weiss AS; Gallin JI; Kaplan AP J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4. Dumenco LL; Everson B; Culp LA; Ratnoff OD J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234 [TBL] [Abstract][Full Text] [Related]
14. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases. España F; Ratnoff OD J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536 [TBL] [Abstract][Full Text] [Related]
15. Relation of the fibrinolytic to other biological systems. Stormorken H Thromb Diath Haemorrh; 1975 Nov; 34(2):378-85. PubMed ID: 128149 [No Abstract] [Full Text] [Related]
19. [Functional interaction of protective systems in the blood]. Sushkevich GN Lab Delo; 1979; (12):707-11. PubMed ID: 93158 [No Abstract] [Full Text] [Related]
20. Inflammation and mediators. Wintroub BU Int J Dermatol; 1980 Oct; 19(8):436-42. PubMed ID: 6109697 [No Abstract] [Full Text] [Related] [Next] [New Search]